Michael Finke, Health Technology and Revenue Cycle Management Thought Leader, Joins Nym Health Board of Directors

NEW YORK, 28 October 2021 / PRNewswire / – Nym Health, a leader in stand-alone medical coding, today announced the appointment of Michael finke to its board of directors. Finke has over 25 years of experience in the development and introduction of machine learning, natural language and speech understanding technologies to the healthcare market, with a focus on reducing the burden of clinical documentation for clinicians while automating revenue cycle processes.

Finke co-founded M * Modal in 2001, a provider of cloud-based, AI-powered clinical documentation and clinical improvement solutions. Under his leadership, more than 5,000 hospitals have adopted M * Modal’s portfolio of clinical intelligence technologies and services, supporting nearly 400,000 physicians. Following the acquisition of M * Modal by 3M in 2019, Finke served as Vice President of 3M Health Information Systems and headed the Clinician Solutions division of the company.

“We are honored to welcome Michael to the Nym Board of Directors as we prepare for this critical next stage of growth,” said Amihai Neiderman, CEO and co-founder of Nym. “Michael brings in-depth domain expertise, which will be invaluable to our team as we continue to expand and enrich the capabilities of our platform to significantly reduce the administrative burden on clinicians and others in healthcare, and , in turn, allow them to spend more time with patients, providing quality and personalized care. “

Powered by sound state-of-the-art clinical language comprehension (CLU) engine and explainable AI capabilities, Nym’s platform improves the speed and accuracy of medical billing, reducing coding costs for healthcare providers. The company’s solution for Revenue Cycle Management (RCM) transforms provider stories into free text in patient charts, turning them into accurate, compliant ICD-10-CM and CPT reimbursement codes in seconds, without no human intervention.

“What attracted me to Nym was their constant focus on enabling a better and deeper understanding of patient history and their overall momentum in the market,” said Finke. “Nym’s unique approach to building truly explainable AI capabilities is critical to overcoming industry challenges related to reliance on the consistent accuracy and quality of AI, which have previously prevented providers from health care to implement technology on a large scale. ”

Earlier in his career, Finke was co-founder and CTO of Interactive Systems (later acquired by Lernout and Hauspie) and held positions at IBM Research, the University of Karlsruhe in Germany and Carnegie Mellon University in Pittsburgh. He obtained his bachelor’s and master’s degrees in computer science at the University of Karlsruhe and is the author of over 100 academic papers. In addition, Finke holds more than 20 patents in the areas of speech recognition, natural language understanding, clinical documentation and coding.

About Nym Santé
Nym Health is a leader in autonomous medical coding. Combining computational linguistics and clinical intelligence, Nym’s innovative approach to Revenue Cycle Management (RCM) cuts costs and improves payment cycles for healthcare providers across United States. With over 96% accuracy, Nym’s technology provides comprehensive, audit-ready, traceable codes for complete transparency. The Nym platform processes more than three million cases per year in more than 90 emergency departments and emergency care departments. Nym has offices at New York and Tel Aviv, Israel, and is backed by Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, Lightspeed and Tiger Global, as well as angel investors, including Zach weinberg and Nat Turner. To learn more about Nym, visit nym.health.

Media contact
Nicole pariser
Nym Health
[email protected]

SOURCE Nym Health

Related links


Comments are closed.